CrossRoads Drug & Alcohol Testing

Our services

Crossroads offers a variety of services relative to the detection of illegal and or controlled substances of abuse. The detection methods include screening urine, hair, or saliva for drugs of abuse. We screen for alcohol in either breath, urine, or saliva.

Drug Testing

We screen for more than 13 popular drugs of abuse. They include Marijuana, Cocaine, Expanded Opioids (codeine, morphine, hydrocodone, hydromorphone, oxycodone) Amphetamine, Methamphetamine, PCP, Benzodiazepine, Propoxyphene, Barbiturates, Methaqualone, and more.

Instant Drug Testing

If you need results on the spot in minutes of testing, we use approved Food and Drug Administration (FDA) and CLIA (Clinical Laboratory Improvement Amendments) POCT (Point Of Care Testing) devices. These devices screen for the same drugs as any laboratory. If a non-negative result, the same sample is sent to a certified laboratory for Gas chromatography-mass spectrometry (GC-MS) confirmation.

Alcohol Testing

Sometimes alcohol testing can be combined with a drug panel and screened for in urine or saliva. The most common method of detection is in a breath sample. We use breath alcohol devices listed on the federally approved compliance list for DOT testing.

Hair Drug Testing

Hair testing analyzes for drugs within the hair shaft, rather than body fluids like urine or saliva, to determine whether drugs of abuse are present. Compared to the analysis of body fluids, hair testing is highly resistant to evasion by adulterating or substituting samples, or by simply abstaining from drug use for a few days. Hair follicle testing detects drugs over 90 days.

Oral Fluids Drug Testing

Just like traditional urine testing, the window in oral fluid testing is different for each drug. What we have found is that oral fluid screening identifies recent usage that can be missed by urine testing. Oral fluid samples provide a close match to drug levels in the blood, identifying donors that are under the influence at the time the sample is collected. Since oral fluid testing detects parent drug and metabolites, depending on the drug, the window of detection in oral fluid starts within one hour of drug usage.



FMSCA Clearing House

The Clearing House is a secure, online database that will give employers and other authorized users real-time information about commercial driver's license (CDL) and commercial learner's permit (CLP) holders' drug and alcohol program violations. The Clearinghouse will improve safety on our Nation's roadways by giving employers and service agents access to information they need to make informed safety decisions about which employees to remove from safety-sensitive functions, including operating a commercial motor vehicle (CMV).

Consortium Third-Party Administration (C/TPA)

Consortium/Third-Party Administrators (C/TPAs) manage all, or part, of an employer's DOT drug and alcohol testing program, sometimes including maintaining required testing records. They perform tasks as agreed to by the employer to assist in implementing the drug and alcohol testing program and to help keep the employer compliant with the DOT/FMCSA Drug and Alcohol Testing rules and regulations.

A consortium will often manage the DOT random testing programs of several employers, including those of owner-operators who are not permitted to manage random testing themselves. Consortiums that manage owner-operator programs play a unique service agent role. The consortium is authorized to perform many employer functions in cases of owner-operators, and single driver employers.

Software

The online application is a virtual Electronic Medical Record system for the Department of Transportation (DOT) or non-DOT drug-free workplace management. It can manage reports for drug test results, medical information, and more. The online application integrates with the LIS HL7 data output for web-reporting.

The desktop software serves well Employers, TPAs, MROs, SAPs, Hospitals, Occupational Health Professionals, and School Administrators. Our drug testing software with great, random selection tools keeps your business in compliance with DOT regulations. It helps achieve your objectives for a Drug-Free Workplace: generate random selections, manage test results, create the DOT MIS Reports. You will also find complete audit trails for your drug testing data needs.

DOT Supervisor Training

Supervisors and company officials overseeing employees (regulated workers) under the FMCSA, FAA, FTA, FRA, and PHMSA — meaning those in the following industries should take the DOT Reasonable Suspicion training: trucking/transportation, airlines, transit, railroad, maintenance of way, pipeline, and hazardous materials. The Federal Department of Transportation Agency Regulations requires that supervisors receive training to determine whether an employee should undergo a Reasonable Suspicion drug test or an alcohol test. The purpose of this Reasonable Suspicion training is to educate supervisors, managers, and company leaders to recognize the effects of drug abuse and alcohol misuse in the workplace. This course will help you meet the DOT mandated training

Collections Site

The procedures for the collection of urine under the Department of Transportation rules are very specific.  We Follow 49 CFR Part 40 procedures whenever we perform a DOT-required urine specimen collection. (The only exception is the Federal Railroad Administration's Post-Accident Toxicological Testing Program in which a railroad representative will provide the collector specific instructions and a testing kit.) The collector has a major role in the success of the DOT's drug-testing program. The collector is the one individual in the testing process with whom all employees have direct, face-to-face contact. Without the collector assuring the integrity of the specimen and collection process, the test itself may lose validity. Without the collector's sensitivity to an employee's privacy, the entire testing program may be subject to criticism. It is imperative that collectors fully understand and follow procedures.

Order a drug test